Prediction of Cognitive Decline by Neuroimaging Techniques &

Status Completed

Clinical Trial Summary

This study is affiliated to Sino Longitudinal Study on Cognitive Decline, SILCODE. To establish models of normal and pathological cognitive aging.To collect the longitudinal data of SCD population, to study the dynamic changes of brain networks so as to explore the progressive mechanisms of AD on brain networks and to construct a high-precision multi-modal model for early diagnosis.

Clinical Trial Description

This study is affiliated to Sino Longitudinal Study on Cognitive Decline, SILCODE. Alzheimer's disease (AD) is the most common cause of dementia, which severely injures multiple domains of cognitive functions in the aging people, bringing heavy burden to the society and families. Studying the cognitive brain damage mechanism of subjective cognitive decline (SCD), the preclinical stage of AD, would provide great opportunities for understanding the pathogenesis of AD and clinical value for early diagnosis and intervention in AD. The project intends to utilize amyloid-PET and FDG-PET for screening and then employ the comprehensive neuropsychological examination combined with multi-modal MRI neuroimaging techniques to study the brain functions and structures of the normal aging and SCD. The imaging data would be analyzed from several levels, including the cognitive dimensions, brain activation patterns, and especially functional and structural networks to establish the models of normal and pathological cognitive aging, which mainly be modulated by frontal-parietal control system. We aim to establish models of normal and pathological cognitive aging. Furthermore, the longitudinal data of SCD population would be collected to study the dynamic changes of brain networks so as to explore the progressive mechanisms of AD on brain networks and to construct a high-precision multi-modal model for early diagnosis ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03370744
Study type	Observational
Source	Xuanwu Hospital, Beijing
Contact
Status	Completed
Phase
Start date	March 15, 2017
Completion date	December 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04121728` - Modulation of Attention in Event Related Potential (ERPs) as a Marker of Early Cognitive Decline by Ginkgo Biloba	N/A
Active, not recruiting	`NCT03271190` - Impact of a Cognitive Intervention Enriched With Leisure Activities in Persons With Subjective Cognitive Decline	N/A
Recruiting	`NCT06078748` - The Lifestyle Exercise and Diet Trial (LEAD) 2.0	N/A
Recruiting	`NCT06287489` - Effects of Mediterranean Diet on Subjective Cognitive Decline	N/A
Recruiting	`NCT05331144` - Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)	Phase 2
Completed	`NCT02969460` - Neurotrack Virtual Cognitive Health Study	N/A
Completed	`NCT03495037` - Preventing Cognitive and Functional Decline Among Seniors at Risk	N/A
Recruiting	`NCT06095063` - dTMS for Subjective Cognitive Decline	N/A
Recruiting	`NCT06110858` - Efficacy of Tinkering Activities in Individuals With Subjective Cognitive Decline	N/A
Active, not recruiting	`NCT04330404` - Effects of Cognitive Strategy Training on Daily Function in People With Subjective Cognitive Decline	N/A
Enrolling by invitation	`NCT03772977` - The Brain Health Champion Study	N/A
Completed	`NCT03236454` - tDCS-enhanced Working Memory Training in Subjective Cognitive Decline	N/A
Not yet recruiting	`NCT06358404` - Developing a Peer Support Intervention for Depression in SCD	N/A
Completed	`NCT04796415` - DEMA-Pro Intervention for Seniors With Subjective Cognitive Decline and Living at Home	N/A
Completed	`NCT04439500` - Effects of Online Training Aimed at Increasing Participation in Everyday Life During a Pandemic (SCD Online).	N/A
Completed	`NCT04880252` - Neuropsychological Indicators of SCD Progression
Completed	`NCT04265378` - Cognitive Training and Brain Stimulation in Prodromal Alzheimer's Disease	N/A
Recruiting	`NCT06335836` - The Effects of Social Isolation and Social Interaction on the Risk of Dementia Progression and Brain Function in SCD (Subjective Cognitive Decline, SCD)
Not yet recruiting	`NCT05225181` - Effects of the Combining Physical Exercise and Cognitive Training for the Community-based Elderly	N/A
Recruiting	`NCT05756270` - Clinical Applicability of pCASL as a Substitute for FDG-PET in MCI and SCD Patients

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Prediction of Cognitive Decline by Neuroimaging Techniques and the Application in Diagnosis and Treatment of Preclinical AD

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms